Tainwala Healthcare Products Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 25 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.00 Cr
as on 23-10-2024
- Revenue 52.03%
(FY 2023)
- Profit 55.26%
(FY 2023)
- Ebitda -131.62%
(FY 2023)
- Net Worth 57.05%
(FY 2023)
- Total Assets 20.49%
(FY 2023)
About Tainwala Healthcare Products
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Agresh Tainwala and Rajkumar Tainwala serve as directors at the Company.
- CIN/LLPIN
U24240MH1999PTC122321
- Company No.
122321
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Oct 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Tainwala Healthcare Products?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajkumar Tainwala  | Director | 21-Oct-1999 | Current |
| Agresh Tainwala | Director | 01-Jun-2015 | Current |
Financial Performance of Tainwala Healthcare Products.
Tainwala Healthcare Products Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 52.03% increase. The company also saw a substantial improvement in profitability, with a 55.26% increase in profit. The company's net worth Soared by an impressive increase of 57.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tainwala Healthcare Products?
In 2023, Tainwala Healthcare Products had a public holding of 0.10%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tainwala Personal Care Products Private LimitedActive 32 years 11 monthsRajkumar Tainwala is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 13 Mar 2006 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Tainwala Healthcare Products?
Unlock and access historical data on people associated with Tainwala Healthcare Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tainwala Healthcare Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tainwala Healthcare Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
